- Home
- CARV vs SNTI Comparison
CARV vs SNTI Comparison
Compare CARV & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- SNTI
- Stock Information
- Founded
- CARV 1948
- SNTI 2016
- Country
- CARV United States
- SNTI United States
- Employees
- CARV N/A
- SNTI N/A
- Industry
- CARV Savings Institutions
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- SNTI Health Care
- Exchange
- CARV Nasdaq
- SNTI Nasdaq
- Market Cap
- CARV 9.0M
- SNTI 10.4M
- IPO Year
- CARV 1994
- SNTI N/A
- Fundamental
- Price
- CARV $1.67
- SNTI $2.17
- Analyst Decision
- CARV
- SNTI
- Analyst Count
- CARV 0
- SNTI 0
- Target Price
- CARV N/A
- SNTI N/A
- AVG Volume (30 Days)
- CARV 22.4K
- SNTI 17.2K
- Earning Date
- CARV 11-14-2024
- SNTI 11-14-2024
- Dividend Yield
- CARV N/A
- SNTI N/A
- EPS Growth
- CARV N/A
- SNTI N/A
- EPS
- CARV N/A
- SNTI N/A
- Revenue
- CARV $28,323,000.00
- SNTI N/A
- Revenue This Year
- CARV N/A
- SNTI $254.47
- Revenue Next Year
- CARV N/A
- SNTI $169.66
- P/E Ratio
- CARV N/A
- SNTI N/A
- Revenue Growth
- CARV 9.41
- SNTI N/A
- 52 Week Low
- CARV $1.26
- SNTI $1.52
- 52 Week High
- CARV $2.39
- SNTI $7.43
- Technical
- Relative Strength Index (RSI)
- CARV 46.23
- SNTI 47.29
- Support Level
- CARV $1.60
- SNTI $2.10
- Resistance Level
- CARV $1.73
- SNTI $2.30
- Average True Range (ATR)
- CARV 0.07
- SNTI 0.17
- MACD
- CARV -0.00
- SNTI 0.00
- Stochastic Oscillator
- CARV 21.87
- SNTI 23.23
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.